Cancer Cell Biology
Tyrosine-nitration of caspase 3 and cytochrome c does not suppress apoptosis induction in squamous cell carcinoma cells
Article first published online: 6 DEC 2002
Copyright © 2002 Wiley-Liss, Inc.
International Journal of Cancer
Volume 103, Issue 6, pages 717–722, 1 March 2003
How to Cite
Ueta, E., Kamatani, T., Yamamoto, T. and Osaki, T. (2003), Tyrosine-nitration of caspase 3 and cytochrome c does not suppress apoptosis induction in squamous cell carcinoma cells. Int. J. Cancer, 103: 717–722. doi: 10.1002/ijc.10832
- Issue published online: 3 JAN 2003
- Article first published online: 6 DEC 2002
- Manuscript Accepted: 30 SEP 2002
- Manuscript Revised: 19 AUG 2002
- Manuscript Received: 25 MAR 2002
- caspase 3;
- cytochrome c;
- squamous cell carcinoma cells;
- anticancer agents
The influence of tyrosine nitration of cytochrome c and caspase 3 on apoptosis induction was investigated in an established squamous carcinoma cell line, OSC-4. The intracellular NO and O levels were increased up to about 110–120% and 140–180% of the control levels, respectively, after the treatment of OSC-4 cells with 5-FU (100 μg/ml), PLM (10 μg/ml), CDDP (10 μg/ml), or γ-rays (20 Gy). The treatment of OSC-4 cells with ONOO− (1 mM) and the above anticancer agents induced tyrosine nitration of 14, 32 kDa protein among others and nitration of tyrosine residues of cytochrome c and caspase 3 was identified by the Western blotting of immunoprecipitates obtained by antibodies to these proapoptotic proteins. When cytochrome c and procaspase 3 were treated with ONOO−, tyrosine nitration was increased in a ONOO−-dose dependent manner. Tyrosine nitration of cleaved (17 kDa) caspase 3, however, was not induced by ONOO−. Procaspase 3 in the cytosol of HeLa cells was activated by the addition of ONOO−-treated as well as ONOO−-untreated cytochrome c. In addition, cleavage of ICAD and PARP were not suppressed in OSC-4 cells by pretreatment with ONOO−. Activity of cleaved caspase 3 was not suppressed at low concentrations or by treatment with ONOO− or NO donors, SIN-1 and SNP. Furthermore, apoptosis of OSC-4 cells by the anticancer agents was not suppressed by ONOO−. In conclusion, these results suggest that nitration of tyrosine residues of cytochrome c and procaspase 3 is induced by chemoradiotherapy but their nitration does not suppress cancer cell apoptosis. © 2002 Wiley-Liss, Inc.
Successful anticancer therapy with chemicals and radiation strongly depends on the strategy for differentiation and apoptosis induction of cancer cells. ROS induce apoptotic signals in cancer cells and apoptosis induction by anticancer drugs and γ-rays is closely associated with intracellular ROS generation.1, 2, 3, 4, 5, 6, 7 Apoptotic signals are transduced mainly through 2 pathways, one of which is originates from the mitochondria and the other is the Fas-associated route.8, 9, 10 The release of the main mitochondrial proapoptotic protein, cytochrome c, is under the regulation of ROS.11, 12 In addition to the generation of ROS, NO is also generated in anticancer drug- and γ-ray-treated cancer cells and reaction of ROS with NO is allowed in a favorable circumstance.13, 14 The reactant ONOO− vigorously damages cells by impairment of proteins and DNA.15, 16, 17, 18, 19 Inactivation of the proapoptotic proteins by ONOO− is therefore probable in chemoradiotherapy of cancers although the apoptosis-inducing activity of ONOO− has been demonstrated in multiple kinds of cancer cells.20, 21
NO reacts with molecular oxygen (O2), O2− and transitional metals, yielding nitrogen dioxide (NO2), ONOO− and metal-nitrosyl adducts, respectively.22, 23, 24 These reactants are highly reactive and exhibit a variety of physiological activities.25 In many disorders including inflammatory diseases, the neurotoxicity of stroke, Alzheimer's disease, Parkinson's disease and multiple sclerosis, the highly reactive nitrogen chemicals, especially ONOO−, are deeply associated with the pathological degeneration of the tissues although the half life of ONOO− is very short, less than one second in the physiological condition.26, 27 ONOO− has a potential to cause DNA-strand breaks, lipid peroxidation and diverse modification of cellular molecules such as oxidation of thiol and methionine and nitration of tyrosine and tryptophane.28 In these modifications, tyrosine nitration has been extensively explored with the aim of analysis of the cytotoxic mechanism of ONOO−.15, 16, 17, 29
A few investigators reported nitration of cytochrome c and s-nitrosylation of caspase 3 by ONOO−, but they did not examine the influence of nitration on the catalytic and proteolytic activities of these proteins.30, 31, 32 Cytochrome c and procaspase 3 have 4 and 10 tyrosine residues, respectively. ONOO− inhibits the electron transport in mitochondria and ONOO− induces nitration of Tyr34 of manganese-superoxide dismutase in the mitochondrial matrices.33 It is likely that when the tyrosine residues of cytochrome c and procaspase 3 are nitrated and these proapoptotic proteins are inactivated, the generation of ONOO− in cancer cells is disadvantageous for apoptosis induction. We report the nitration of cytochrome c and procaspase 3 by ONOO− and the influence of their tyrosine nitration on apoptosis using a squamous cell carcinoma cell line.
MATERIAL AND METHODS
HeLa cells, a cell line established from a cervical carcinoma and OSC-4 cells, an oral squamous cell carcinoma cell line that has a silent point mutation of the p53 gene at codon 174 (AGGAGA),34 were used in our study. They were cultured in DMEM supplemented with 10% FBS. In every examination, the subconfluent phases of the monolayered cultured cells were used.
Preparation of ONOO−
Peroxynitrite was prepared by the reaction of equivalent volume of H2O2 and 2-methoxyethyl nitrite under basic condition as described by Lin et al.35 Peroxynitrite was produced by mixing 1.5 ml of H2O2 (0.1 M) with 1.5 ml of 2 N sodium hydroxide and 7 ml of distilled H2O. To the mixture, 0.15 ml (1.6 mM) of 2-methoxyethyl nitrite was added at room temperature. The yielded ONOO− was quantified by UV spectrum of the solution 15 min after the mixing (λmax = 302 nm: ϵ = 1,670 ± 50 l/mol cm). The light yellow solution of ONOO− (150–200 mM) was stored at −80°C for an extended time. Aliquots of ONOO− were monitored spectroscopically at 302 nm to accurately determine the concentration before and after each experiment.
Treatment of OSC-4 cells
OSC-4 cells cultured in 100 mm dishes were treated with 5-FU (100 μg/ml, Kyowa Hakko Co., Tokyo), CDDP (10 μg/ml, Nihon Kayaku Co., Tokyo) or PLM (10 μg/ml, a bleomycin derivative, Nihon Kayaku Co.) for 6–48 hr at 37°C in the presence or absence of 150 or 1,000 μM peroxynitrite. The cells were then harvested and used for the examination. After irradiation (20 Gy) with 137Cs, OSC-4 cells were cultured as described above and harvested for the examination.
Assay of intracellular NO and O level
Intracellular NO and O levels were assayed by flow cytometry using 4,5-diaminofluorescein diacetate (10 μM) and hydroethidine (2 μM) purchased from Sigma (St. Louis, MO) and Molecular Probes (Eugene, OR). The intramitochondrial O level was also assayed by flow cytometry using hydroethidine with mitochondrial fraction.
Assay of cytochrome c activity
Cytochrome c from horse hearts (Sigma) (0.5 μg/ml) were treated with 0.1–1,000 μM peroxynitrite for 1 hr at 37°C. To assess whether the tyrosine-nitrated cytochrome c can induce an activation of Apaf-1 and caspase 3, an S100 fraction containing Apaf-1, procaspase-9 and procaspase 3 was prepared from HeLa cells as follows. HeLa cells (3 × 106) were suspended in 500 μl of buffer A (50 mM HEPES-KOH, pH 7.5 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM dithiothreitol) containing 250 mM sucrose and a mixture of protease inhibitors (1 mM PMSF, 1% aprotinin, 1 mM leupeptin, 1 μg/ml pepstatin A and 1 μg/ml chymostatin). The cells were homogenized in the same buffer solution, with a glass Pyrex homogenizer using a Type B pestle (40 strokes). Unbroken cells, large plasma membrane fragments and nuclei were removed by centrifugation at 1,000g at 4°C for 10 min. The resulting supernatant was subjected to centrifugation at 10,000g at 4°C for 20 min. The supernatant was recentrifuged at 100,000g at 4°C for 1 hr and the final supernatant was used as the S100 fraction. Cytochrome c, which was treated with or without peroxynitrite, was mixed with the S100 fraction for 4 hr at 37°C. The mixture was used for the sample for Western blot analysis using anti-cleaved caspase-3 antibody (Cell Signaling Technology, Beverly, MA).
Western blot analysis and immunoprecipitation
Whole-cell extracts were prepared and Western blot analysis was carried out as described by An and Dou.36 To perform a coupled immunoprecipitation-Western blot analysis, the whole cell extract (200 μg protein/ml) was incubated with protein A agarose beads (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 4°C for 2 hr. The collected supernatant was incubated for greater than 3 hr with 10 μl of agarose beads conjugated with either anti-cytochrome c antibody (Pharmingen, San Diego, CA) or anti-caspase 3 antibody (Transduction Laboratories, Lexington, KY), followed by incubation with Protein A beads at 4°C overnight. The washed immunoprecipitates were boiled in SDS sample buffer and used for Western blotting with antibody to 3-nitrotyrosine (UBI, Lake Placid, NY).
OSC-4 cells were pretreated with 150 μM ONOO− for 1 hr at 37°C and irradiated with 20 Gy of γ-rays or treated with 100 μg/ml of 5-FU, 10 μg/ml of CDDP or 10 μg/ml of PLM. After 48 hr from the start of treatment, cells were harvested. Cleavage of PARP and ICAD was then detected by Western blot analysis using anti-cleaved PARP antibody (Cell Signaling Technology) and anti-DFF45 antibody (ProSci Inc., Poway, CA).
Assay of caspase 3 activity
Recombinant procaspse-3 (MBL, Nagoya, Japan) (0.5 μg/ml) and recombinant active caspase 3 (MBL) (0.5 μg/ml) were treated with 0.1–1000 μM peroxynitrite or 25–400 μM SNP or SIN-1 for 1 hr at 37°C. Then, caspase 3 activity was detected using a caspase 3 colorimetric kit (Sigma), based on the hydrolysis of Ac-DEVD-p-nitroaniline (pNA) by caspase 3, resulting in the release of the pNA moiety. PNA was detected at 405 nm (ϵmM = 10.5). The specificity for caspase 3 activity was demonstrated by inhibition with 10 nM Ac-DEVD-CHO.
Intracellular NO and O levels after OSC-4 cell treatment with NO donors and anticancer agents
The intracellular NO level was dose-dependently increased by SNP and SIN-1 (Fig. 1). In the presence of 10 μM, 100 μM and 1,000 μM of SNP, intracellular NO was increased up to 132, 147.5 and 161 arbitrary units, respectively. A similar increase in the NO level was observed by the addition of SIN-1, although the degree of the increase was lower than that in SNP. The anticancer agents upregulated the intracellular NO level but the increases were weak. The maximal NO levels after treatment with 5-FU (100 μg/ml), PLM (10 μg/ml), CDDP (10 μg/ml) and γ-rays (20 Gy) were 114, 113, 112.5 and 106 arbitrary units, respectively.
Generation of O was enhanced by all anticancer agents examined (Fig. 2). Of the agents, 5-FU most strongly increased cytosolic and intramitochondrial O levels. The highest levels in both fractions were 181 ± 7 and 85 ± 6 arbitrary units, respectively, which were about 181.5% and 152.9% of each control level, respectively. Near increases of O levels was observed in CDDP and PLM-treated OSC-4 cells, but the increase of O by γ-rays was remarkably weaker than that by 5-FU.
Tyrosine nitration of cellular proteins and cytochrome c
Tyrosine nitration was weakly observed in 14, 25, 32, 40 and 42 kDa proteins from cell lysates of non-treated OSC-4 cells and the nitration levels in these proteins were weakly increased when OSC-4 cells were treated with 100 μg/ml 5-FU, 10 μg/ml CDDP for 6 hr or irradiated with 137Cs as much as 20 Gy (Fig. 3a). The nitration of the tyrosine residues was further increased after the 24-hr treatment with the same dose of each above agent (Fig. 3b). The tyrosine nitration was furthermore strengthened by the addition of 150 μM ONOO− to the culture medium. The immunoblot with anti-nitrotyrosine antibody of precipitates by anti-cytochrome c antibody showed that nitration of tyrosine residues of cytochrome c was induced by treatment of OSC-4 cells with 5-FU, CDDP and γ-rays and the nitration levels were increased in the presence of peroxynitrite (Fig. 4a). The 14 kDa protein, purified cytochrome c from horse hearts, underwent nitration by ONOO− in a dose-dependent manner (Fig. 4b). Cytochrome c showed a weak nitration of the tyrosine-residues in the absence of ONOO− and the nitration reached the maximal level in the presence of 100 μM ONOO−.
Tyrosine nitration of procaspase 3 and cleaved caspase 3
Enhanced tyrosine nitration of procaspase 3 by treatment with 5-FU, CDDP, PLM and γ-rays was observed by immunoblotting of the caspase 3 immunoprecipitates lysates with anti-nitrotyrosine AB (Fig. 5a). The bands of tyrosine-nitrated procaspase 3 were thickened after 24 hr treatment with each anticancer drug and γ-rays although the increase in nitration by 3 hr treatment was very weak. Cleaved (active) caspase 3 was treated with ONOO− but nitration of the tyrosine residues was not observed (data not shown) and the cleaved caspase 3 was blotted at 34 kDa and 51 kDa (Fig. 5b).
Influence of tyrosine nitration on cytochrome c and cleaved caspase 3 activities
To examine the influence of tyrosine nitration of cytochrome c on its activity, cytochrome c was treated with 10 μM to 1,000 μM ONOO− for 1 hr and mixed with the cytosol obtained from HeLa cells. By mixing, procaspase 3 was cleaved into 17 and 19 kDa proteins (Fig. 6a). The cleavage levels in the addition of ONOO−-pretreated cytochrome c was similar to that in the addition of ONOO−-untreated cytochrome c.
The cleaved caspase 3 activity was not suppressed by 150 nM ONOO− and only slightly decreased by 1.5 μM, 15 μM and 150 μM ONOO− although the activity was strongly diminished by 1,500 μM ONOO− (Fig. 6b). NO donors, SNP and SIN-1, suppressed the caspase 3 activity in a dose-dependent manner but the suppression of caspase 3 activity by SNP and SIN-1 up to the concentration of 50 μM was very weak, although the activity was decreased down to about three-fifths and half of the control level by 200 μM and 400 μM of SNP and SIN-1, respectively (Fig. 6c).
Influence of ONOO− on the apoptosis induction
Pretreatment of OSC-4 cells with 150 μM ONOO− did not affect 5-FU-, CDDP-, PLM- and γ-ray-induced cleavage of PARP (Fig. 7a) and ICAD (Fig. 7b) and similar levels of cleavage of both proteins were observed in OSC-4 cells with and without the pretreatment. The DNA fragmentation induced by these anticancer agents was not decreased by 150 μM ONOO− and no influence of ONOO− on apoptosis of OSC-4-cells was ascertained by Nick-end labeling immunochemical stainings (data not shown).
There are some signal pathways involved in the induction of apoptosis. One of the pathways is the Fas (CD95/APO-1)-mediated signal flow and the other pathway is associated with the release of mitochondrial cytochrome c, which is under the regulation of Bcl-2 family proteins.8, 9, 10 Although the cytochrome c release is induced by the signal from Fas, the main signal for the release of cytochrome c is the reduction of mitochondrial membrane potential associated with ROS with an involvement of Bcl-2 family proteins.35, 36, 37, 38, 39, 40, 41 In addition, ROS also play an important role in protein phosphorylation and activation of nuclear factor-kappa B (NF-κB) and activating protein-1 (AP-1), which are both associated with apoptosis.42, 43 In OSC-4 cells used in the present study, the main apoptotic pathway seemed to be associated with cytochrome c release from the mitochondria.6
ROS react with NO and highly reactive molecules are generated. Of these, ONOO−, which is formed by the reaction of NO and O, is extremely reactive.22, 23 The impairment of proteins and DNA by ONOO− has been studied thoroughly.15, 16, 17, 18, 19 In addition, ONOO− induces nitration of proteins and DNA. Many investigators have reported that nitration of tyrosine residues impaired the function of the protein by suppressing the phosphorylation of the protein and decreasing the enzyme activity.30, 44, 45, 46, 47, 48, 49, 50 It was reported recently that nitration of a c-Src kinase induced cell growth in an adenocarcinoma cell line and that tyrosine nitration had no effect on the function of some proteins associating with cell death.51, 52 These contradicting findings explain the unexploration of the influence of protein nitration.
In the present study, nitration of tyrosine residues of some proteins was observed in untreated cancer cells. This result seems to suggest that NO and ROS are generated de novo and nitric compounds are synthesized. The nitration level was, however, increased by cell treatment with γ-rays and anticancer drugs. The increase in protein nitration was coordinated with the 10–20% increase in the intracellular NO level and 40–80% increase in the O2− level. Although the estimation method of intracellular ONOO− has not been developed and we could not examine the ONOO− concentration in the cells, the results showed that ONOO− was generated intracellularly by the treatment with the anticancer agents and the generated ONOO−-induced protein nitration.
An increased nitration of tyrosine residues of cytochrome c and procaspase 3 was shown by the Western blots of their immunoprecipitates and it was clarified that tyrosine nitration was increased by ONOO− in a dose-dependent manner. The protease activities of cytochrome c and caspase 3 were, however, scarcely decreased by ONOO− up to 150 μM although more higher concentrations of ONOO− largely decreased their activities. The intracellular NO levels in γ-rays and anticancer drug-treated cells were low and the ONOO− levels in the treated OSC-4 cells were suggested to be lower than 150 μM. The low NO levels suggest that in cancer chemoradiotherapy, any suppression of cytochrome c or caspase 3 activity by nitration is not induced even if some degrees of ONOO− are generated in the cancer cells. This seems to be supported by the finding that a relatively high concentration of ONOO− did not suppress the cleavage of ICAD and PARP by caspase 3.
Cassina et al.28 reported that of 4 tyrosine residues of cytochrome c, Tyr-67 was nitrated by ONOO− and that the heme-vicinal Tyr-67 nitration promoted a conformational change in cytochrome c decreasing its activity. Our present study, however, showed no decrease in the cytochrome c activity by nitration when the ONOO−concentration was lower than 150 μM. The lack of influence on the activity is probably derived from the finding in our present study that the nitrated tyrosine residue(s) was far from the domain that is responsible for the activity of cytochrome c.
Tyrosine nitration was observed in procaspase 3 but was not observed in cleaved, activated caspase 3. Procaspase 3 possesses 10 tyrosine residues and cleaved caspase 3 has 3 (Tyr-37, Tyr-41, Tyr-83). These 3 residues seemed not to be nitrated. The non-nitration of these tyrosine residues is probably associated with the non-decrease in cleaved caspase 3 activity in ONOO−-treated cells.
When cleaved caspase 3 was treated with ONOO− and blotted with anti-cleaved caspase 3 antibody, bands of 34 kDa and 51 kDa were observed and the expression of these bands was increased in an ONOO− dose-dependent manner (Fig. 5b). These bands suggested dimerization and trimerization of the cleaved caspase 3. As described above, the cleaved caspase 3 activity was largely suppressed by ONOO− concentrations higher than 150 μM and the dimerization was strong at the high concentrations of ONOO−. There is a possibility that severe polymerization of cleaved caspase 3 is responsible for the inactivation of cleaved caspase 3. To accurately decide the influence of protein nitration, the relation between the position of nitrated tyrosines and caspase 3 activity should be determined.
- 49Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 1997; 49: 681–97., , , , .